Sennosides and Docusate Sodium description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Sennosides and Docusate Sodium

McKesson Packaging Services a business unit of McKesson Corporation

Drug Facts


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Active ingredient

Docusate Sodium 50mg

Sennosides 8.6 mg

Purpose

Docusate Sodium...............Stool Softener

Sennosides.........................Stimulant Laxative

Keep Out of Reach of Children

Sennosides and Docusate Sodium Uses

  • relieves occasional constipation (irregularity)
  • generally causes bowel movement in 6-12 hours

Warnings

Do Not Use

  • this product if you are presently taking mineral oil, unless directed by a doctor
  • laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • a sudden change in bowel movements that persists over 2 weeks

Stop use and ask a doctor if

  • You have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition.
  • If pregnant or breast -feeding, ask a health professional before use.
  • Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away

Directions

  • Take preferably at bedtime or as directed by a doctor
  • If you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed the maximum dosage) or decrease dose until you are comfortable.
Age Starting Dose Maximum Dose
Adults and children 12 years of age and older 2 tablets once a day 4 tablets twice a day
Children 6 to under 12 years 1 tablet once a day 2 tablets twice a day
Children 2 to under 6 years 1/2 tablet once a day 1 tablets twice a day
Children under 2 years ask a doctor ask a doctor

Other Information

  • each tablet contains calcium 20mg, sodium 6mg (LOW SODIUM)
  • store at 25°C (77°F)

Inactive ingredients

carnauba wax, colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate dihydrate, D&C yellow #10 aluminum lake, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium benzoate, stearic acid, titanium dioxide, **tapioca starch, **tartaric acid

** may contain one or more of these ingredients

Package/Label Principal Display Panel

Sennosides and Docusate Sodium

Sennosides and Docusate Sodium

Sennosides and Docusate Sodium TABLET

Product Information

Product Type Human otc drug label Item Code (Source) NDC:63739-432
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
SENNOSIDES SENNOSIDES 8.6 mg
DOCUSATE SODIUM DOCUSATE 50 mg

Inactive Ingredients

Ingredient Name Strength
carnauba wax
SILICON DIOXIDE
CROSCARMELLOSE SODIUM
ANHYDROUS DIBASIC CALCIUM PHOSPHATE
D&C YELLOW NO. 10
FD&C YELLOW NO. 6
HYPROMELLOSES
MAGNESIUM STEARATE
cellulose, microcrystalline
POLYETHYLENE GLYCOLS
SODIUM BENZOATE
STEARIC ACID
titanium dioxide
STARCH, TAPIOCA

Product Characteristics

Color Size Imprint Code Shape
ORANGE 5 mm TCL;081 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 10 in 1 BLISTER PACK
2 30 in 1 BLISTER PACK
3 30 in 1 BLISTER PACK
4 NDC:63739-432-04 25 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
2007-10-11


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.